午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

IMidazo[1,2-a]pyrazine, 5,6,7,8-tetrahydro-2,3-diMethyl-

IMidazo[1,2-a]pyrazine, 5,6,7,8-tetrahydro-2,3-diMethyl- Struktur
1250515-54-8
CAS-Nr.
1250515-54-8
Englisch Name:
IMidazo[1,2-a]pyrazine, 5,6,7,8-tetrahydro-2,3-diMethyl-
Synonyma:
2,3-Dimethyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazine;2,3-Dimethyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazine (~85%);2,3-Dimethyl-5,6,7,8-tetrahydro-imidazo[1,2-a]pyrazine;IMidazo[1,2-a]pyrazine, 5,6,7,8-tetrahydro-2,3-diMethyl-
CBNumber:
CB62608198
Summenformel:
C8H13N3
Molgewicht:
151.21
MOL-Datei:
1250515-54-8.mol

IMidazo[1,2-a]pyrazine, 5,6,7,8-tetrahydro-2,3-diMethyl- Eigenschaften

Schmelzpunkt:
58-75°C
storage temp. 
-20°C Freezer, Under inert atmosphere
L?slichkeit
Chloroform (Slightly), DMSO (Slightly)
Aggregatzustand
Solid
Farbe
Brown to Dark Brown

Sicherheit

IMidazo[1,2-a]pyrazine, 5,6,7,8-tetrahydro-2,3-diMethyl- Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

2,3-Dimethyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazine is used in the preparation of a pluripotent stem cell inhibitor.

IMidazo[1,2-a]pyrazine, 5,6,7,8-tetrahydro-2,3-diMethyl- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

IMidazo[1,2-a]pyrazine, 5,6,7,8-tetrahydro-2,3-diMethyl- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aikon International Limited 025-58851090 15955137747
 sales01@aikonchem.com China 15949 58
Shanghai Haohong Scientific Co., Ltd. 400-8210725 4008210725
 malulu@leyan.com China 39984 58
Biosynth Biological Technology (Suzhou) Co Ltd 51288865780
 sales@biosynth.com China 6051 58
Beijing Pubiao Technology Co., Ltd. 18618179058
CHINA 0 58
  • IMidazo[1,2-a]pyrazine, 5,6,7,8-tetrahydro-2,3-diMethyl-
  • 2,3-Dimethyl-5,6,7,8-tetrahydro-imidazo[1,2-a]pyrazine
  • 2,3-Dimethyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazine (~85%)
  • 2,3-Dimethyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazine
  • 1250515-54-8
Copyright 2019 ? ChemicalBook. All rights reserved